您当前所在的位置:首页 > 产品中心 > 产品详细信息
1420-55-9 分子结构
点击图片或这里关闭

2-(ethylsulfanyl)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine

ChemBase编号:256
分子式:C22H29N3S2
平均质量:399.61576
单一同位素质量:399.18028994
SMILES和InChIs

SMILES:
S1c2c(N(CCCN3CCN(CC3)C)c3c1cccc3)cc(SCC)cc2
Canonical SMILES:
CCSc1ccc2c(c1)N(CCCN1CCN(CC1)C)c1c(S2)cccc1
InChI:
InChI=1S/C22H29N3S2/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24/h4-5,7-10,17H,3,6,11-16H2,1-2H3
InChIKey:
XCTYLCDETUVOIP-UHFFFAOYSA-N

引用这个纪录

CBID:256 http://www.chembase.cn/molecule-256.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
2-(ethylsulfanyl)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine
IUPAC传统名
thiethylperazine
商标名
Norzine
Torecan
别名
Ethylthioperazine
Theithylperazine
Thiethylperazine
CAS号
1420-55-9
PubChem SID
160963719
46506502
PubChem CID
5440
CHEBI ID
9544
ATC码
R06AD03
CHEMBL
1378
Chemspider ID
5245
DrugBank ID
DB00372
KEGG ID
D02354
美国药典/FDA物质标识码
8ETK1WAF6R
维基百科标题
Thiethylperazine

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
质子受体 质子供体
LogD (pH = 5.5) 1.858934  LogD (pH = 7.4) 3.623811 
Log P 4.6593223  摩尔折射率 122.5583 cm3
极化性 47.19488 Å3 极化表面积 9.72 Å2
可自由旋转的化学键 里宾斯基五规则 true 
Log P 5.12  LOG S -4.91 
溶解度 4.87e-03 g/l 

分子性质

分子性质

理化性质 药理学性质 生物活性(PubChem)
溶解度
0.0584 mg/L expand 查看数据来源
疏水性(logP)
5 expand 查看数据来源
蛋白结合率
60% expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank Wikipedia Wikipedia
DrugBank -  DB00372 external link
Item Information
Drug Groups approved
Description A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
Indication For the treatment or relief of nausea and vomiting.
Pharmacology Thiethylperazine, an atypical antipsychotic agent, is used to treat both negative and positive symptoms of schizophrenia, acute mania with bipolar disorder, agitation, and psychotic symptoms in dementia. Future uses may include the treatment of obsessive-compulsive disorder and severe behavioral disorders in autism. Structurally and pharmacologically similar to clozapine, Thiethylperazine binds to alpha(1), dopamine, histamine H1, muscarinic, and serotonin type 2 (5-HT2) receptors.
Toxicity Manifestations of acute overdosage of TORECAN (thiethylperazine) can be expected to reflect the CNS effects of the drug and include extrapyramidal symptoms (E.P.S), confusion and convulsions with reduced or absent reflexes, respiratory depression and hypotension.
Affected Organisms
Humans and other mammals
Protein Binding 60%
Elimination Thiethylperazine is eliminated in the urine.
References
Maurer H, Pfleger K: Identification of phenothiazine antihistamines and their metabolites in urine. Arch Toxicol. 1988;62(2-3):185-91. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Maurer H, Pfleger K: Identification of phenothiazine antihistamines and their metabolites in urine. Arch Toxicol. 1988;62(2-3):185-91. Pubmed
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle